We’re experiencing what medical experts describe as “a sea change” in lung cancer treatment options.
Yet, developing new treatments is only half the battle. As doctors and researchers develop new treatments for this incurable disease, patients face insurance companies, government bureaucracies and cost-cutting institutes that can create barriers for patients in their ability to access these life-saving innovations.
We’re mobilizing patients to fight back.
Voices of Value Speak UP: Non-Small Cell Lung Cancer is the first part of a national six-event program presented by Patients Rising and Aimed Alliance.
Our goal is simple: protect every patient’s right to access life-saving treatments.
If you are a non-small cell lung cancer patient or know someone who is — we invite you to join us for a free evening of dinner, drinks and value. Even if you are not a lung cancer patient, but you believe it’s wrong for pharmacies and insurers to restrict access to treatments, we’d love to see you, too.
You’ll hear real patients speaking out on value and why it is important for patients to answer the economic institutes that are creating creating roadblacks between patients and innovative lung cancer treatment options.
We believe that the true measure of value in our health care system starts with the concerns and goals of patients.
Come share your story with us. We want to meet you. We want to hear you.
This is an interactive event: Free Dinner — Live Webcast — Live Polling — Hear from Patients — Hear from Experts — Hear from YOU!
Jonathan Wilcox, our co-founder and policy director, will moderate an all-star panel, including:
What is non-small cell cancer?
According to the National Cancer Institute: “Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.” Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are all subtypes of non-small cell lung cancer.
Each type of non-small cell lung cancer has different kinds of cancer cells. The cancer cells of each type grow and spread in different ways. The types of non-small cell lung cancer are named for the kinds of cells found in the cancer and how the cells look under a microscope:
The American Cancer Society says that non-small cell lung cancer is the most common type of lung cancer, encompassing about 85% of lung cancers.
Without a cure, innovation is critical for patients with non-small cell lung cancer. So is getting access to the right treatment — and the flexibility to switch to a new treatment when one fails to show meaningful results.
Learn more by checking out our Beginner’s Guide to Non-Small Cell Lung Cancer.
Get notified about new stories and resources to empower patients and caregivers.